Stem Cell Transplant Course Fall 2024

November 6, 2024 to November 13, 2024

Target Audience

The course is designed for registered nurses and other healthcare professionals involved in caring for patients undergoing stem cell transplant.  Six months to one year of oncology experience and the completion of the Foundations to Practice Series (Pathophysiology of Cancer, Cancer Treatment Modalities, and the Immune System; Overview of Solid Tumors; Symptom Management of Patients with Cancer; Oncology Emergencies and Advanced Cancer Care Issues; and Hematological Malignancies, and Antineoplastic Therapy and Immunotherapy Course or other introductory cancer courses are strongly recommended. 

Learning Objectives

The learner will be able to:

  1. Discuss the role of stem cell transplant in cancer and other diseases.
  2. Compare and contrast the role of autologous, allogeneic, haploidentical, and cord blood transplant in treating hematological malignancies.
  3. Understand preparative regimen chemotherapy and what preparative regimen is indicated based on disease and other comorbidities.
  4. Understand the transfusion needs surrounding patients who need or receive a stem cell transplant. 
  5. Describe appropriate interventions for the management of transplant associated complications including acute and chronic graft verse host disease, infection, and organ toxicities.
  6. Describe the process of pre transplant evaluation, mobilization, cell collection, cell infusion, and troubleshooting infusion related complications for transplant patients and donors. 
  7. Understand HLA typing and donor selection for allogeneic and haploidentical transplants. 
  8. Understand the purpose and importance of immunosuppression in the stem cell transplant population. 
  9. Identify the role of rehabilitation resources in patients undergoing stem cell transplant.
  10. Understand the short term and long term follow up requirements and role of survivorship care planning, including patient education across the transplant continuum of care. 
  11. Recall the clinical background of chimeric antigen receptor modified T-cells and the diseases indicated for this type of treatment.
  12. Discuss the outpatient management of a stem cell transplant patient.
  13. Recall the nursing care considerations of a patient receiving CAR T-cell therapy.
Course summary
Available credit: 
  • 13.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 13.00 APA
  • 13.00 Attendance
Course opens: 
05/24/2024
Course expires: 
11/21/2024
Event starts: 
11/06/2024 - 8:00am EST
Event ends: 
11/13/2024 - 4:00pm EST
Add to calendar: 
UPMC Hillman Cancer Center
Pittsburgh, PA
United States

Holly Angelo, DPT
Physical Therapist
UPMC Shadyside Hospital

Melissa Bastacky, PharmD, BCOP
Oncology Clinical Pharmacist
UPMC Shadyside

Amanda Blasko, BSN, RN
Oncology Clinical Coordinator
UPMC Hillman Cancer Center

Ashur-Dee Brown, MSN, RN, BMTCN
Program Manager
Cellular Therapy
UPMC Hillman Cancer Center

Sawa Ito, MD, PhD
Assistant Professor
Hematopoietic Stem Cell Transplant and Cell Therapy
Department of Medicine
University of Pittsburgh

Shannon Joy, CRNP
Nurse Practitioner
Palliative Care
Inpatient Consult Service
UPMC Shadyside

Wendy Lucas, MSN, RN, CCRN, CCNS, BMTCN
Advanced Clinical Education Specialist
UPMC Shadyside Hospital

Megan Marmol, BSN, RN
Sr. Professional Staff Nurse
UPMC Shadyside 6 West

Nichole Miller, PA-C
Physician Assistant
Stem Cell Transplant Service
University of Pittsburgh Physicians

Jennifer Minnier, PA-C
Physician Assistant
Stem Cell Transplant Service
University of Pittsburgh Physicians

Melissa Potter, MSW, LCSW, OSW-C, Clinical Social Worker
Lemieux Center for Blood Cancers
UPMC Hillman Cancer Center

Heather Poole, CRNP
Hematology Oncology
Inpatient BMT UPMC Hillman Cancer Center and
UPMC Shadyside

Brittni Prosdocimo, MSN, RN, BMTCN
Advanced Clinical Education Specialist
Manager, Professional and Patient Education
UPMC Hillman Cancer Center

Alison Sehgal, MD, MS
Clinical Assistant Professor of Medicine
University of Pittsburgh Medical Center
UPMC Hillman Cancer Center

Cheryl Tompkins MSN, CRNP, BMTCN
Nurse Practitioner, Senior
Stem Cell Transplant Service
University of Pittsburgh Physicians

Darrell Triulzi, MD
Professor of Pathology
University of Pittsburgh
Medical Director the Institute for Transfusion Medicine

Jackie Wojton, BSN, RN, OCN
Clinician, 6 West
UPMC Shadyside 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours. 

To receive 13 Contact Hours, the learner must sign in attendance each day, attend both days of the course virtually via TEAMS, and complete the activity evaluation.

Available Credit

  • 13.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 13.00 APA
  • 13.00 Attendance
Please login or register to take this course.